Delivery Order SPE2DB25D7067-SPE2DB25FSVFW

Award Date 6/13/25
Potential Completion Date 6/16/25
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NALTREXONE 50 MG TABLET 60S, with a ceiling value of $13,284.14 and a completion date of May 23, 2025. The contract is a firm-fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,721.53, is for the supply of NALTREXONE 50 MG TABLET 90S, a medication used in the treatment of opioid use disorder. The contract is a firm fixed-price delivery order with an ultimate completion date of October 31, 2023. AmerisourceBergen holds a larger Indefinite Delivery...
This is a $14,187.84 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NALTREXONE 50 MG TABLET 60S, a medication used in the treatment of opioid and alcohol dependence. The contract has a firm fixed price and an ultimate completion date of February 10, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Naltrexone 50 mg tablets. The contract has a total ceiling value of $12,406.98 and a performance period through November 26, 2024. It is a firm fixed price contract, meaning the price does not change regardless of the actual costs incurred by the contractor. The contract is not associated with any specific set-aside requirement, indicating open competition. Amerisourcebergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for NALTREXONE 50 MG TABLET 90S at a firm fixed price of $2,821.44. The contract has a completion date of February 15, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $4,945.60 order is for the supply of NALTREXONE 50 MG TABLET 90S, a pharmaceutical product, with a completion date of February 21, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, which has a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Naltrexone 50 mg tablets, a medication used to treat opioid addiction. The contract is a firm-fixed price delivery order with a ceiling value of $7,192.66 and a period of performance ending on May 2, 2025. This order is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,482.80, is for the delivery of NALTREXONE 50 MG TABLET 60S, a medication used in the treatment of opioid and alcohol dependence. The contract has a completion date of February 24, 2025 and is a Firm Fixed Price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,332.54, is for the delivery of 60-count packages of the pharmaceutical product Naltrexone 50 mg tablets. The contract has a completion date of November 18, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with an ID of SPE2DB22D3009|SPE2DB25FAK53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566544752 ! NALTREXONE 50 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $7,015.06. The contract type is a Delivery Order with a Firm Fixed Price pricing arrangement, and the ultimate completion date is November 26,...
  • SPE2DB25D7067
    Indefinite Delivery Contract
  • SPE2DB25D7067-SPE2DB25FSVFW
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NALTREXONE 50 MG TABLET 100S, with a ceiling value of $3,911.20 and a period of performance through June 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 9/12/25, 10:53 AM